Regulation of phosphate uptake in primary cultured rabbit renal proximal tubule cells by glucocorticoids: Evidence for nongenomic as well as genomic mechanisms
Sh. Park et al., Regulation of phosphate uptake in primary cultured rabbit renal proximal tubule cells by glucocorticoids: Evidence for nongenomic as well as genomic mechanisms, ENDOCRINOL, 142(2), 2001, pp. 710-720
We have investigated the nongenomic as well as the genomic effects of gluco
corticoids on phosphate (Pi) uptake in primary rabbit renal proximal tubule
cells (PTCs) and have defined the involved signaling pathways. In the pres
ent study, cortisol-BSA (cortisol-BSA) (>10(-9) M, 30 min) was found to inh
ibit Pi uptake in a time- and concentration-dependent manner. However, prog
esterone-BSA (P-4-BSA), 17 beta -estradiol-BSA (E-2-BSA), testosterone-BSA
(T-4-BSA), aldosterone, P-4, E-2, and T-4 (10(-9) M, 1 h) had no effect on
Pi uptake. In addition, cortisol-BSA (10-9 hr) did not affect either Naf up
take or alpha -methylglucopyranoside (cr-MG) uptake. The cortisol-BSA-induc
ed inhibition of Pi uptake was associated with a decrease in the V-max for
Pi uptake, rather than the K-m. The inhibitory effect of cortisol-BSA was n
ot blocked either by actinomycin D (an inhibitor of transcription), cyclohe
ximide (an inhibitor of translation), or classical glucocorticoid receptor
antagonists (RU 486 or P-4). The cortisol-BSA-induced inhibition of Pi upta
ke was blocked by two phospholipase C (PLC) inhibitors (neomycin or U73122)
, and two protein kinase C (PKC) inhibitors (staurosporine or bisindolylmal
eimide I) but not by two adenylate cyclase/protein kinase A inhibitors [SQ
22536 (an adenylate cyclase inhibitor) or myristoylated protein kinase A in
hibitor amide 14-22]. Furthermore, cortisol-BSA promoted the translocation
of PKC from the cytosolic fraction to the membrane fraction, while having n
o effect on the activity of adenylate cyclase. Our observations may thus be
interpreted as indicating that cortisol does indeed inhibit renal Pi uptak
e via a nongenomic mechanism, which involves the PLC/PKC pathway.